Reviewing the journey to the clinical application of bacteriophages to treat multi-drug-resistant bacteria
Gerald Mboowa
Abstract
Antimicrobial resistance (AMR) was a leading cause of death globally in 2019. Sadly, COVID-19 has exacerbated AMR, nonetheless, the process of developing new antibiotics remains very challenging. This urgently requires the adoption of alternative approaches to treat multi-drug-resistant bacterial infections. This editorial introduces the 'Bacteriophages against multi-drug resistant bacteria' collection launched at BMC Infectious Diseases which highlights progress towards using bacteriophages to tackle AMR.
Topics & Concepts
Medical microbiologyDrug resistanceAntibiotic resistanceAntibioticsIntensive care medicineAntimicrobial drugMedicineAntimicrobialCoronavirus disease 2019 (COVID-19)DrugMicrobiologyClinical microbiologyInfectious disease (medical specialty)VirologyBiologyPharmacologyDiseaseInternal medicineBacteriophages and microbial interactionsGenomics and Phylogenetic StudiesMicrobial Community Ecology and Physiology